---
title: "QuidelOrtho to Report Second Quarter 2026 Financial Results | QDEL Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293748470.md"
description: "QuidelOrtho Corporation (Nasdaq: QDEL) announced it will report its second quarter 2026 financial results for the period ended June 28, 2026, after market close on Thursday, August 6, 2026. A conference call to discuss these results will follow at 2:00 p.m. PT / 5:00 p.m. ET. Presentation materials and a replay of the call will be available on the company's Investor Relations website."
datetime: "2026-07-24T03:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293748470.md)
  - [en](https://longbridge.com/en/news/293748470.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293748470.md)
generator: "portal-rs"
---

# QuidelOrtho to Report Second Quarter 2026 Financial Results | QDEL Stock News

, /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will report its financial results for the second quarter 2026 ended June 28, 2026, after the market closes on Thursday, August 6, 2026.

Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

**About QuidelOrtho Corporation**

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:  
Juliet Cunningham  
Vice President, Investor Relations  
IR@QuidelOrtho.com

Media Contact:  
Stephanie Kleewein  
Senior Corporate Communications and PR Manager  
media@QuidelOrtho.com

SOURCE QuidelOrtho Corporation

### Related Stocks

- [QDEL.US](https://longbridge.com/en/quote/QDEL.US.md)

## Related News & Research

- [Xcel Energy sets BRL 0.26 per unit distribution for payment Oct. 26, 2026](https://longbridge.com/en/news/296646864.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/296518280.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)
- [Baker Hughes declares Q3 2026 dividend of R$ 0.81 per unit](https://longbridge.com/en/news/296392545.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**